Orobol: An Isoflavone Exhibiting Regulatory Multifunctionality against Four Pathological Features of Alzheimer's Disease

ACS Chem Neurosci. 2019 Aug 21;10(8):3386-3390. doi: 10.1021/acschemneuro.9b00232. Epub 2019 Jun 20.

Abstract

We report orobol as a multifunctional isoflavone with the ability to (i) modulate the aggregation pathways of both metal-free and metal-bound amyloid-β, (ii) interact with metal ions, (iii) scavenge free radicals, and (iv) inhibit the activity of acetylcholinesterase. Such a framework with multifunctionality could be useful for developing chemical reagents to advance our understanding of multifaceted pathologies of neurodegenerative disorders, including Alzheimer's disease.

Keywords: Multifunctionality; acetylcholinesterase; amyloid-β; flavonoid; free radicals; metal−amyloid-β.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholinesterase / drug effects
  • Alzheimer Disease* / pathology
  • Amyloid beta-Peptides / chemistry
  • Amyloid beta-Peptides / drug effects*
  • Animals
  • Enzyme Inhibitors / pharmacology
  • Flavonoids / chemistry
  • Flavonoids / pharmacology*
  • Free Radical Scavengers / pharmacology
  • Humans
  • Protein Aggregation, Pathological / drug therapy*

Substances

  • Amyloid beta-Peptides
  • Enzyme Inhibitors
  • Flavonoids
  • Free Radical Scavengers
  • Acetylcholinesterase
  • orobol